Header Logo

Connection

DANIEL MUSHER to Staphylococcus aureus

Back to Details
This is a "connection" page, showing publications DANIEL MUSHER has written about Staphylococcus aureus.
DANIEL MUSHER
Connection Strength
1.954
Staphylococcus aureus
  1. Does active hepatitis C virus infection increase the risk for infection due to Staphylococcus aureus? Eur J Clin Microbiol Infect Dis. 2017 Jul; 36(7):1217-1223.
    View in: PubMed
    Score: 0.431
  2. Benefits and costs of rapid drug susceptibility in Staphylococcus aureus bacteremia. Clin Infect Dis. 2011 Apr 15; 52(8):1079; author reply 1079-80.
    View in: PubMed
    Score: 0.288
  3. The association between Staphylococcus aureus bacteremia and acute myocardial infarction. Scand J Infect Dis. 2009; 41(6-7):511-4.
    View in: PubMed
    Score: 0.246
  4. A 57-year-old man with a fluid-containing lung cavity: infection of an emphysematous bulla with methicillin-resistant Staphylococcus aureus. Chest. 2006 Dec; 130(6):1942-6.
    View in: PubMed
    Score: 0.213
  5. Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother. 2006 Sep; 58(3):680-3.
    View in: PubMed
    Score: 0.207
  6. Clinical significance of Staphylococcus aureus bacteriuria at a tertiary care hospital. Scand J Infect Dis. 2013 Sep; 45(9):688-95.
    View in: PubMed
    Score: 0.084
  7. Impact of an assay that enables rapid determination of Staphylococcus species and their drug susceptibility on the treatment of patients with positive blood culture results. Infect Control Hosp Epidemiol. 2010 Oct; 31(10):1043-8.
    View in: PubMed
    Score: 0.069
  8. Outcomes of treatment for hematogenous Staphylococcus aureus vertebral osteomyelitis in the MRSA ERA. J Infect. 2008 Aug; 57(2):128-31.
    View in: PubMed
    Score: 0.059
  9. Community-associated strains of methicillin-resistant Staphylococccus aureus as the cause of healthcare-associated infection. Infect Control Hosp Epidemiol. 2006 Oct; 27(10):1051-6.
    View in: PubMed
    Score: 0.052
  10. In vitro killing of community-associated methicillin-resistant Staphylococcus aureus with drug combinations. Antimicrob Agents Chemother. 2004 Oct; 48(10):4016-9.
    View in: PubMed
    Score: 0.046
  11. Suppression of phagocytosis and chemotaxis by cell wall components of Staphylococcus aureus. J Immunol. 1981 Jul; 127(1):84-8.
    View in: PubMed
    Score: 0.037
  12. Two forms of Staphylococcus aureus in blood of patients with staphylococcal sepsis. J Clin Microbiol. 1979 Jan; 9(1):23-7.
    View in: PubMed
    Score: 0.031
  13. Emergence of variant forms of Staphylococcus aureus after exposure to gentamicin and infectivity of the variants in experimental animals. J Infect Dis. 1977 Sep; 136(3):360-9.
    View in: PubMed
    Score: 0.028
  14. Increasing rates of Staphylococcus aureus bacteremia--a medical device is a merit in disguise and methicillin resistance is merely a vice. Clin Infect Dis. 1996 Aug; 23(2):260-1.
    View in: PubMed
    Score: 0.026
  15. Device-related infective endocarditis, with special consideration of implanted intravascular and cardiac devices in a predominantly male population. Scand J Infect Dis. 2012 Oct; 44(10):753-60.
    View in: PubMed
    Score: 0.020
  16. The effect of HIV infection on phagocytosis and killing of Staphylococcus aureus by human pulmonary alveolar macrophages. Am J Med Sci. 1990 Mar; 299(3):158-63.
    View in: PubMed
    Score: 0.017
  17. Fluid-containing emphysematous bullae: a spectrum of illness. Eur Respir J. 2008 Aug; 32(2):303-6.
    View in: PubMed
    Score: 0.015
  18. Phagocytosis and killing of common bacterial pathogens of the lung by human alveolar macrophages. J Infect Dis. 1985 Jul; 152(1):4-13.
    View in: PubMed
    Score: 0.012
  19. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine (Baltimore). 2003 Sep; 82(5):322-32.
    View in: PubMed
    Score: 0.011
  20. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine (Baltimore). 2003 Sep; 82(5):333-9.
    View in: PubMed
    Score: 0.011
  21. Tolerant Staphylococcus aureus causing vertebral osteomyelitis. Arch Intern Med. 1982 Mar; 142(3):632-4.
    View in: PubMed
    Score: 0.010
  22. Bacterial adherence to pharyngeal cells during viral infection. J Infect Dis. 1980 Feb; 141(2):172-6.
    View in: PubMed
    Score: 0.008
  23. Bacterial adherence to pharyngeal cells in smokers, nonsmokers, and chronic bronchitics. Infect Immun. 1979 Oct; 26(1):178-82.
    View in: PubMed
    Score: 0.008
  24. Osteomyelitis: recent clinical and laboratory aspects. Orthop Clin North Am. 1979 Apr; 10(2):347-59.
    View in: PubMed
    Score: 0.008
  25. Infections due to Staphylococcus aureus. Medicine (Baltimore). 1977 Sep; 56(5):383-409.
    View in: PubMed
    Score: 0.007
  26. Levels of rifampin and ciprofloxacin in nasal secretions: correlation with MIC90 and eradication of nasopharyngeal carriage of bacteria. J Infect Dis. 1990 Nov; 162(5):1124-7.
    View in: PubMed
    Score: 0.004
  27. Human alveolar lining material and antibacterial defenses. Am Rev Respir Dis. 1986 Jan; 133(1):136-40.
    View in: PubMed
    Score: 0.003
  28. The effect of staphylococcal peptidoglycan on polymorphonuclear leukocytes in vitro and in vivo. Scand J Infect Dis Suppl. 1983; 41:79-86.
    View in: PubMed
    Score: 0.003
  29. Hypoglycemia as a manifestation of sepsis. Am J Med. 1980 May; 68(5):649-54.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.